Skip to main content

Month: April 2025

Completion of share split

Company announcementfor ROCKWOOL A/SRelease no. 22 – 2025to Nasdaq Copenhagen         11 April 2025 Completion of share split At the Annual General Meeting of ROCKWOOL A/S (the “Company”) held on 2 April 2025, it was resolved to complete a share split in the ratio of 1:10, whereby each existing share with a nominal value of 10 DKK would be divided into 10 shares with a nominal value of 1 DKK. The share split has now been completed. Following completion of the share split, the Company’s share capital consists of nominally 216,207,090 DKK, divided into 216,207,090 shares with a nominal value of 1 DKK, of which 98,178,390 are A shares and 118,028,700 are B shares. Further information:         Kim Junge AndersenSenior Vice President, CFOROCKWOOL A/S+45 46 55 80 15AttachmentSE-2025-22_EN

Continue reading

Notice to the Annual General Meeting of KH Group Plc

KH Group PlcStock Exchange Release 11 April 2025 at  10:00 am EEST Notice to the Annual General Meeting of KH Group Plc Notice is given to the shareholders of KH Group Plc (“KH Group” or the “Company”) to the Annual General Meeting to be held on Tuesday, 6 May 2025 at 2:00 p.m. EEST at Sanomatalo, Flik Event Studio Eliel, at the address Töölönlahdenkatu 2, 00100 Helsinki, Finland. The reception of attendees who have registered for the meeting and the distribution of voting tickets will commence at 1:30 p.m. EEST. Shareholders may also exercise their voting rights by voting in advance. Shareholders who have registered for the meeting may also follow the meeting via a live webcast. Further instructions for shareholders are provided in section C “Instructions for the participants in the Annual General Meeting” of this notice. In connection...

Continue reading

Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia 

Singapore, April 11, 2025 (GLOBE NEWSWIRE) — Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider specializing in diagnostic imaging and outpatient care. The agreement marks a significant step in Basel Medical Group’s strategic expansion in Singapore and the broader Southeast Asian healthcare market. The completion of the acquisition is subject to customary closing conditions and is expected to take place on or around April 30, 2025 or such other date agreed by the parties. Strategic Partnership Evolves into Full Integration Basel Medical Group and Bethesda Medical have been collaborating on strategic partnerships aimed at enhancing patient care and operational...

Continue reading

SMCP – Kleine TAN appointed as CEO of SMCP Asia

Press Release – Paris, April 11th, 2025 Kleine TAN appointed as CEO of SMCP Asia SMCP Group, parent company of the Sandro, Maje, Claudie Pierlot and Fursac brands, is pleased to announce the appointment of Kleine Tan as CEO of SMCP Asia, effective April 1st, 2025. He succeeds Jimmy Lam who has decided to pursue new opportunities outside the Group. Isabelle Guichot, CEO of SMCP Group, said: “I am very pleased to welcome Kleine Tan as CEO of SMCP Asia. Having lived and worked in Asia for the past two decades, Kleine brings a solid international perspective and a deep understanding of the retail and wholesale dynamics across the Asia-Pacific region. As we continue to implement our strategic roadmap in the region, notably with our network optimization in China, I am confident that Kleine will bring a new pragmatic and expert vision to the...

Continue reading

Publication annual report 2024, convening notice for the General Meeting and proposal new directors

Publication annual report 2024, convening notice for the General Meeting and proposal new directors Regulated information 11 April 2025, 8 am CET Kinepolis Group NV presents its integrated annual report 2024, with a comprehensive overview of the Group’s strategic, financial, operational and ESG performance for the year 2024. The report is available in English and Dutch and can be accessed via this link. Kinepolis’ annual report 2024 is the first report prepared in accordance with the guidelines of the EU’s Corporate Sustainability Reporting Directive (CSRD). It contains information on policies, actions and performance indicators regarding Kinepolis’ sustainability priorities, based on an analysis of current and potential impacts, risks and opportunities. With a clear vision of the future of cinema, Kinepolis is...

Continue reading

Fenix Outdoor International AG Invitation to AGM May 5th

Invitation to the ordinary General Meeting of Shareholders of Fenix Outdoor International AG The Board of Directors is pleased to invite you to the ordinary General Meeting concerning the financial year 2024. Date:         Thursday, 5 May 2025, 2 pmPlace:        Hemvärnsgatan 9, Solna (Sweden)                             I.      Notification Shareholders who wish to attend (in person, representation by proxy or by the Independent Proxy) the ordinary General Meeting must be recorded in the Company’s share register by Thursday, 24 April 2025 at the latest and must notify the Company no later than Tuesday, 29 April 2025, 1 p.m. by telephone +46 660 26 62 00, by mail to Fenix Outdoor International AG, Solna Strandvag 128 B, 171 54 Solna (Sweden) or by e-mail info@fenixoutdoor.se of their attendance. An e-mail from the Company confirming...

Continue reading

Fagron publishes agenda for 2025 annual shareholders meeting

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to attend Fagron’s annual general meeting of shareholders on Monday 12 May 2025. AgendaThe agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.35 for the financial year 2024, and the approval of the remuneration policy. The full agenda and further details can be found in the meeting documents. Meeting and meeting documentsFagron’s annual general meeting of shareholders will be held at its statutory seat, Venecoweg 20A, 9810, Nazareth (Belgium) and by audio and video conference on Monday 12 May 2025 at 3PM CET. The convocation, including the agenda,...

Continue reading

Bekaert – Update on the Share Buyback Program and Liquidity Agreement

Update on the Share Buyback Program and the Liquidity Agreement Period from 3 April 2025 to 9 April 2025 Share Buyback ProgramOn 28 February 2025, Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 25 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 3 April 2025 to 9 April 2025, Kepler Cheuvreux SA on behalf of Bekaert has bought 70 000 shares. The table below provides an overview of the transactions under the Program during the period from 3 April 2025 to 9 April 2025:  Repurchase of sharesDate Market Number of Shares Average Price paid (€) Highest Price paid (€) Lowest Price paid (€) Total Amount (€)3 April 2025 Euronext Brussels 10 000 31.70 3 250.00 30.92 316 964  MTF...

Continue reading

NORBIT ASA – Notice of Annual General Meeting on 6 May 2025

Trondheim, 11 April 2025: The Annual General Meeting of NORBIT ASA will be held on Tuesday 6 May 2025 at 4:00 pm CET as a physical meeting at Stiklestadveien 1, Trondheim. Shareholders who are not able to attend the meeting are encouraged to vote in advance or submit a proxy form prior to the meeting. Attached please find the following documents:The notice of the general meeting, including the proposed resolutions and attendance and proxy forms The proposals from the nomination committee for the general meeting The board of directors’ report on salary and other remuneration for leading personnel for 2024All documents to be processed in the meeting, including access to electronic registration and proxy, will be made available at the company’s website www.norbit.com. To access the electronic system for notification of attendance, reference...

Continue reading

Tryg A/S – Interim report Q1 2025

 Tryg’s Supervisory Board has today approved the interim report Q1 2025. Tryg reported an insurance service result of DKK 1,540m (DKK 1,280m) and a combined ratio of 84.2% (86.6%) in Q1 2025. The higher insurance service result was supported by a growth of 3.7% in local currencies, a benign level of weather claims, and a continued underlying profitability improvement. The investment result was robust at DKK 320m (DKK 112m). Pre-tax profit was DKK 1,491m (DKK 1,007m) and profit after tax was DKK 1,118m (DKK 776m). Ordinary dividend of DKK 2.05 (DKK 1.95) per share for the quarter, is an increase of more than 5% from last year. The reported solvency ratio at the end of Q1 2025 was 195%, supporting future shareholder remuneration. Tryg launched a DKK 2bn buyback on 4 December 2024, of which some DKK 1.3bn has been bought back at the end of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.